4.6 Article

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma

Journal

BMC CANCER
Volume 22, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12885-022-10128-y

Keywords

Pancreatic adenocarcinoma; SDC4; TCGA; GTEx; Clinicopathological feature; Survival curve; Poor prognosis; Independent risk factor

Categories

Funding

  1. Project of Science and Technology of Guizhou Province [080]
  2. Project of High-level Innovative Talents Training Program Ten level Talents of Guizhou Province [5647]
  3. Project of Hepatobiliary Surgery Clinical Medicine Research Center of Guizhou Province [5404]
  4. Project of Health and Family Planning Commission Science and Technology Fund of Guizhou Province [gzwkj2021-167]
  5. Project of Science and Technology project of Guiyang city, Zhu ke He Tong [[2019]9-1-26]

Ask authors/readers for more resources

This study aimed to explore the expression and clinical significance of SDC4 in pancreatic adenocarcinoma (PAAD). The results showed that SDC4 was highly expressed in PAAD tissues and correlated with reduced overall survival. Pathway analysis also revealed the enrichment of important pathways associated with SDC4. High expression of SDC4 was associated with metastatic differentiation, TNM stage, lymphatic metastasis, and lower 3-year survival rate, and it was identified as an independent risk factor affecting postoperative survival.
Objective: Pancreatic adenocarcinoma (PAAD) is a leading cause of cancer-related mortality in adults. Syndecan-4 (SDC4) is involved in cancer pathogenesis. Therefore, this study aimed to explore the expression and clinical significance of SDC4 in PAAD. Methods: Differentially expressed genes (DEGs) between PAAD and normal pancreas were screened from the GTEx and TCGA databases, and the correlationship between the DEGs and prognosis were analyzed. The prognostic value of the screened SDC4, SERPINE1, and SLC2A1 was evaluated using the Kaplan-Meier curve and SDC4 was subsequently selected as the better candidate. Also, SDC4 expression was analyzed in PAAD tissues, the other risk factors affecting postoperative survival were analyzed using Cox regression analysis, and SDC4-mediated pathways enrichment was identified by GSVA and GSEA. SDC4 expression in PAAD tissues and adjacent normal tissues of selected PAAD patients was detected by RT-qPCR and immunohistochemistry. The correlation between SDC4 and clinical features was evaluated by the chi(2) test. Results: SDC4 was highly expressed in PAAD tissues. Elevated SDC4 was correlated with reduced overall survival. SDC4 enrichment pathways included spliceosome function, proteasome activity, pentose phosphate pathway, base excision repair, mismatch repair, DNA replication, oxidative phosphorylation, mitotic spindle formation, epithelialmesenchymal transition, and G2M checkpoints. SDC4 was elevated in PAAD tissues of PAAD patients compared with adjacent normal tissues. High SDC4 expression was related to metastatic differentiation, TNM stage, lymphatic metastasis, and lower 3-year survival rate. SDC4 was an independent risk factor affecting postoperative survival. Conclusion: SDC4 was highly expressed in PAAD and was related to clinicopathological features and poor prognosis, which might be an important index for PAAD early diagnosis and prognosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available